Lineage Cell Therapeutics, Inc. · AMEX:LCTX
Broadwood Partners, L.P. bought 1,000,000 Lineage Cell Therapeutics, Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 19, 2026
On Nov 17, 2026, Broadwood Partners, L.P. (Director, 10% owner) bought 1,000,000 Lineage Cell Therapeutics, Inc. shares at US$0.77 for US$771K, leaving 50,560,992 shares. Filed Nov 19, 2026 (Form 4).
- Bought
- 1,000,000 shares
- Price
- US$0.77
- Value
- US$771K
- Holding after
- 50,560,992 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Shares | Buy | 1,000,000 | US$0.77 | 50,560,992 | Direct |
| Nov 17, 2026 | Common Shares | Buy | 0 | 50,560,992 | Indirect |
Source
Download original · View original at SEC
Related
- Lineage Cell Therapeutics, Inc.
- Broadwood Partners, L.P.
- Lineage Cell Therapeutics, Inc. shareholders
- Form 4 · Mulroy Michael H. · Nov 19, 2026
- Form 4 · Andrews Deborah J · Nov 17, 2026
- Form 4 · Culley Brian M · Nov 17, 2026
- Form 4 · Howe Jill Ann · Nov 16, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026